Search News
| 7.15 Delayed Data As of Apr 24 |  +0.14 / +2.00%Today’s Change | 6.71 Today|||52-Week Range 11.93 | -12.80% Year-to-Date |
| Previous close | 7.01 |
| Today’s open | 6.98 |
| Day’s range | 6.98 - 7.18 |
| Volume | 283,490 |
| Average volume (3 months) | 413,340 |
| Market cap | $289.9M |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -473.39% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +16.26% |
| P/E ratio | 4.4 |
| Price/Sales | 1.97 |
| Price/Book | 3.39 |
| Today’s change | Today’s % change | |
|---|---|---|
| IOVAIovance Biotherapeut... | -0.15 | -1.03% |
| GLYCGlycoMimetics Inc | -0.94 | -5.30% |
| TLGTTeligent Inc | +0.05 | +1.46% |
| DEPODepomed Inc | +0.04 | +0.59% |
| Next reporting date | May 8, 2018 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $174.2M |
| Annual profit (last year) | $67.8M |
| Net profit margin | 38.93% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Michael Shannon Anderson |
Chief Operating Officer & Executive Vice President Gregory J. Divis |
Corporate headquarters Dublin, Dublin |
